These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22718202)

  • 1. Hospitalization due to respiratory syncytial virus infection in patients under 2 years of age with hemodynamically significant congenital heart disease.
    Andres S; Bauer G; Rodríguez S; Novali L; Micheli D; Fariña D
    J Pediatr (Rio J); 2012 May; 88(3):246-52. PubMed ID: 22718202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: A cohort study.
    Benítez-Guerra D; Piña-Flores C; Zamora-López M; Escalante-Padrón F; Lima-Rogel V; González-Ortiz AM; Guevara-Tovar M; Bernal-Silva S; Benito-Cruz B; Castillo-Martínez F; Martínez-Rodríguez LE; Ramírez-Ojeda V; Tello-Martínez N; Lomelí-Valdez R; Salto-Quintana J; Cadena-Mota S; Noyola DE
    Influenza Other Respir Viruses; 2020 Mar; 14(2):182-188. PubMed ID: 31917902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus infection in Guatemala, 2007-2012.
    McCracken JP; Prill MM; Arvelo W; Lindblade KA; López MR; Estevez A; Müller ML; Muñoz F; Bernart C; Cortez M; Moir JC; Ortíz J; Paredes A; Iwane MK
    J Infect Dis; 2013 Dec; 208 Suppl 3():S197-206. PubMed ID: 24265479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus-associated hospitalizations over three consecutive seasons in children with congenital heart disease.
    Resch B; Kurath-Koller S; Hahn J; Raith W; Köstenberger M; Gamillscheg A
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1165-9. PubMed ID: 27126331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
    Chaw PS; Wong SWL; Cunningham S; Campbell H; Mikolajczyk R; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S613-S619. PubMed ID: 31599958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area.
    Chiu SN; Shao PL; Chen HC; Lin MT; Huang LM; Kao FY; Huang SK; Wang JK; Wu MH
    J Pediatr; 2016 Apr; 171():25-30.e1. PubMed ID: 26822618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018.
    Nyawanda BO; Murunga N; Otieno NA; Bigogo G; Nyiro JU; Vodicka E; Bulterys M; Nokes DJ; Munywoki PK; Emukule GO
    BMC Med; 2023 Mar; 21(1):122. PubMed ID: 37004034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.
    Friedman D; Fryzek J; Jiang X; Bloomfield A; Ambrose CS; Wong PC
    PLoS One; 2017; 12(3):e0172512. PubMed ID: 28253361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.
    Iwane MK; Edwards KM; Szilagyi PG; Walker FJ; Griffin MR; Weinberg GA; Coulen C; Poehling KA; Shone LP; Balter S; Hall CB; Erdman DD; Wooten K; Schwartz B;
    Pediatrics; 2004 Jun; 113(6):1758-64. PubMed ID: 15173503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease.
    Duppenthaler A; Ammann RA; Gorgievski-Hrisoho M; Pfammatter JP; Aebi C
    Arch Dis Child; 2004 Oct; 89(10):961-5. PubMed ID: 15383442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
    Shi T; Denouel A; Tietjen AK; Campbell I; Moran E; Li X; Campbell H; Demont C; Nyawanda BO; Chu HY; Stoszek SK; Krishnan A; Openshaw P; Falsey AR; Nair H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S577-S583. PubMed ID: 30880339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Risk Factors for Respiratory Syncytial Virus and Human Metapneumovirus Infections among Children in the Remote Highlands of Peru.
    Wu A; Budge PJ; Williams J; Griffin MR; Edwards KM; Johnson M; Zhu Y; Hartinger S; Verastegui H; Gil AI; Lanata CF; Grijalva CG
    PLoS One; 2015; 10(6):e0130233. PubMed ID: 26107630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study.
    Kang JM; Lee J; Kim YK; Cho HK; Park SE; Kim KH; Kim MJ; Kim S; Kim YJ
    Pediatr Int; 2019 Jul; 61(7):688-696. PubMed ID: 31107995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care costs of hospitalization of young children for respiratory syncytial virus infections: a population-based matched cohort study.
    Thampi N; Knight BD; Thavorn K; Webster RJ; Lanctot K; Hawken S; McNally JD
    CMAJ Open; 2021; 9(4):E948-E956. PubMed ID: 34667075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.
    Hall CB; Weinberg GA; Blumkin AK; Edwards KM; Staat MA; Schultz AF; Poehling KA; Szilagyi PG; Griffin MR; Williams JV; Zhu Y; Grijalva CG; Prill MM; Iwane MK
    Pediatrics; 2013 Aug; 132(2):e341-8. PubMed ID: 23878043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors for acute respiratory syncytial virus infection of lower respiratory tract in hospitalized infants].
    Zhang X; Liu L; Shi P; Jiang G; Jia P; Wang C; Wang L; Qian L
    Zhonghua Er Ke Za Zhi; 2014 May; 52(5):373-7. PubMed ID: 24969937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes.
    Cai W; Buda S; Schuler E; Hirve S; Zhang W; Haas W
    Influenza Other Respir Viruses; 2020 Nov; 14(6):658-670. PubMed ID: 32064773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.